Mostafa El-Serafi

403 total citations
10 papers, 309 citations indexed

About

Mostafa El-Serafi is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Mostafa El-Serafi has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Mostafa El-Serafi's work include Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). Mostafa El-Serafi is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). Mostafa El-Serafi collaborates with scholars based in Egypt, South Korea and Portugal. Mostafa El-Serafi's co-authors include Abeer A. Bahnassy, Abdel‐Rahman N. Zekri, Amal El‐Shehaby, J. Wils, Manfred P. Lutz, C.-H. Köhne, Eric Van Cutsem, Carsten Bokemeyer, Bernard Nordlinger and M. Lorenz and has published in prestigious journals such as Cancer, European Journal of Cancer and Acta Oncologica.

In The Last Decade

Mostafa El-Serafi

10 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mostafa El-Serafi Egypt	8	201	82	72	59	57	10	309
Kunihiro Hamada Japan	11	146 0.7×	147 1.8×	96 1.3×	53 0.9×	81 1.4×	22	328
H. Doucas United Kingdom	11	178 0.9×	138 1.7×	97 1.3×	28 0.5×	74 1.3×	11	330
Şahin Laçin Türkiye	10	98 0.5×	69 0.8×	46 0.6×	33 0.6×	38 0.7×	37	242
Christopher Rall United States	12	221 1.1×	111 1.4×	103 1.4×	81 1.4×	53 0.9×	18	404
Aphrodite Nonni Greece	9	118 0.6×	118 1.4×	62 0.9×	106 1.8×	35 0.6×	29	372
Lucian Miron Romania	9	125 0.6×	75 0.9×	31 0.4×	74 1.3×	76 1.3×	44	296
W. Messersmith United States	5	206 1.0×	96 1.2×	22 0.3×	37 0.6×	87 1.5×	9	302
Zhao Yin-nong China	10	114 0.6×	156 1.9×	99 1.4×	55 0.9×	42 0.7×	24	406
Zahi Merjaneh United States	2	160 0.8×	122 1.5×	67 0.9×	47 0.8×	81 1.4×	5	332

Countries citing papers authored by Mostafa El-Serafi

Since Specialization

Citations

This map shows the geographic impact of Mostafa El-Serafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa El-Serafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa El-Serafi more than expected).

Fields of papers citing papers by Mostafa El-Serafi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa El-Serafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa El-Serafi. The network helps show where Mostafa El-Serafi may publish in the future.

Co-authorship network of co-authors of Mostafa El-Serafi

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa El-Serafi. A scholar is included among the top collaborators of Mostafa El-Serafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa El-Serafi. Mostafa El-Serafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

El-Serafi, Mostafa, et al.. (2018). First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study. Journal of the Egyptian National Cancer Institute. 30(1). 13–20. 10 indexed citations

Park, Young Suk, Jiafu Ji, John Zalcberg, et al.. (2015). Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry. Asia-Pacific Journal of Clinical Oncology. 11(4). 334–342. 8 indexed citations

El-Serafi, Mostafa, Abeer A. Bahnassy, N ALI, et al.. (2010). The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer. Cancer. 116(21). 4954–4964. 26 indexed citations

Popov, I, Alfredo Carrato, Alberto Sobrero, et al.. (2008). Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). European Journal of Cancer. 44(15). 2204–2211. 37 indexed citations

Esmat, Gamal, A. Yosry, Mostafa El-Serafi, et al.. (2005). Donor Outcomes in Right Lobe Adult Living Donor Liver Transplantation: Single-Center Experience in Egypt. Transplantation Proceedings. 37(7). 3147–3150. 14 indexed citations

Bahnassy, Abeer A., et al.. (2004). Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterology. 4(1). 22–22. 123 indexed citations

Gaafar, Rabab, Hussein Khaled, Mostafa El-Serafi, et al.. (2004). Gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: National Cancer Institute Cairo experience.. PubMed. 16(1). 1–7. 4 indexed citations

Köhne, C.-H., Eric Van Cutsem, J. Wils, et al.. (2003). 1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986. European Journal of Cancer Supplements. 1(5). S325–S326. 57 indexed citations

Shamaa, Sameh, et al.. (2000). J P-glycoprotein expression in resistant or relapsing Hodgkin?s disease.. Journal of the Egyptian National Cancer Institute. 12(1). 41–50. 1 indexed citations

10.

El-Serafi, Mostafa, et al.. (1989). Chemotherapy in Invasive Carcinoma of the Bladder A review of phase II trials in Egypt. Acta Oncologica. 28(1). 73–76. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact